Log in to search using one of your social media accounts:

 

Parasite Drug Shows Effectiveness Against Mesothelioma

Dr. Antonio Giordano believes his team has cleared the path to the next breakthrough in the treatment of malignant pleural mesothelioma. The advancement involves a new use for an old drug, pyrvinium pamoate, which doctors have successfully used for more than 50 years to treat infections of pinworm parasite. “This drug that no one expected to be involved with mesothelioma is potentially a new weapon against this aggressive type of tumor,” Giordano told Asbestos.com. “Our findings are exciting, very exciting. This one can move forward.” Giordano is the founder and director of the Sbarro Health Research Organization (SHRO) at Temple University in Philadelphia. He also is an internationally renowned professor of pathology and oncology at the University of Sienna in Italy. His expertise involves identifying novel targets and therapies at the molecular level. This particular drug has shown promise with mesothelioma as well as pancreatic and breast cancer. Better Mesothelioma Treatments Needed The findings have been published in the latest issue of Journal of Cell Physiology. A summary is available on the SHRO website. “This should trigger interest and attention of oncologists all over the world to work on it,” Giordano said. “It’s now about taking the initiative to bring this drug to the clinical bedside, to the patients.” Pleural mesothelioma, which is caused by exposure to asbestos, is a rare and aggressive cancer with no defi...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

Conclusion: Our current data revealed that anti-vimentin antibodies induced during T. cruzi infection could be a marker of active disease in the host and its levels could also justify drug therapy in American Trypanosomiasis chronic infection, as a large group of asymptomatic patients would be submitted to treatment with frequent adverse reactions of the available drugs. Anti-vimentin antibodies could be a marker of cardiac muscle cell damage, appearing in American Trypanosomiasis patients during active muscle cell damage.Resumo Fundamento: A Vimentina é uma proteína estrutural importante da célula, um...
Source: Arquivos Brasileiros de Cardiologia - Category: Cardiology Source Type: research
Cancer patients get inundated with advice, how much of it can be trusted?
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: News Source Type: news
Date: Monday, 06 04, 2018; Speaker: Taro Yamashita, M.D., PhD, Associate Professor, Kanazawa University Hospital; Building: Building 37; 4041
Source: NIH Calendar of Events - Category: American Health Source Type: events
Date: Thursday, 06 07, 2018; Speaker: Claire Vajdic, Ph.D., Head of the Cancer Epidemiology Research Unit, The University of New South Wales; Webinar
Source: NIH Calendar of Events - Category: American Health Source Type: events
Administering androgen deprivation therapy (ADT) to men with low-risk prostate cancer improves some short-term outcomes. But is it still active surveillance? And do otherwise healthy men need treatment?Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
NHS HEROES AWARDS 2018 aired on ITV tonight, and among those leading the tributes were Prince William and the Duchess of Cornwall. One mum was handed an award for raising millions of pounds to fund cancer research after her son lost his three year fight with the disease. The type of cancer he had was rhabdomyosarcoma - what are its symptoms?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
The largest cancer meeting in the world is coming up soon, but early release of abstracts means that data to be presented are already making news.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
San Antonio is getting more than a world-renowned cancer researcher with the addition of Patrick Sung.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Grandview Medical Center has named Jennifer De Los Santos as the medical director of the new Grandview Cancer Center.   Dr. De Los Santos has been nationally recognized for her work in radiation oncology, specifically her research in breast cancer treatment. Prior to joining Grandview, she was an associate scientist and professor at the University of Alabama at Birmingham in the department of radiation oncolog y. She also served as medical director of The Kirklin Clinic.  Dr. De Los Santos has…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Early exposure to microbes may help protect children against a type of leukaemia, says a UK scientist.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
More News: Asbestosis | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Enterobiasis | Environmental Health | Genetics | Immunotherapy | Italy Health | Laboratory Medicine | Mesothelioma | Pancreas | Pancreatic Cancer | Parasitic Diseases | Parasitology | Pathology | Physiology | Study | Websites